37970556|t|Induction of MYCN-amplified neuroblastoma differentiation through NMYC suppression using PPAR-gamma antagonist.
37970556|a|Neuroblastomas are the most common extracranial solid tumors in children and have a unique feature of neuronal differentiation. Peroxisome proliferator-activated receptor (PPAR)-gamma is reported to have neuroprotective effects in addition to having antitumor effects in various cancers. Thus, we aimed to clarify the role of PPAR-gamma agonist and antagonist in malignant neuroblastomas, which also possess neuronal features. In MYCN-amplified neuroblastoma CHP212 cells, treatment with the PPAR-gamma antagonist GW9662 induced growth inhibition in a dose-dependent manner. In addition, the PPAR-gamma antagonist treatment changed cell morphology with increasing expression of the neuronal differentiation marker tubulin beta 3 (TUBB3) and induced G1 phase arrest and apoptosis in MYCN-amplified neuroblastoma. Notably, the PPAR-gamma antagonist treatment significantly decreased expression of NMYC, B-cell lymphoma 2 (BCL2) and bromodomain-containing protein 4 (BRD4). It is implied that BRD4, NMYC, BCL2 suppression by the PPAR-gamma antagonist resulted in cell growth inhibition, differentiation, and apoptosis induction. In our in vivo study, the PPAR-gamma antagonist treatment induced CHP212 cells differentiation and resultant tumor growth inhibition. Our results provide a deeper understanding of the mechanisms of tumor cell differentiation and suggest that PPAR-gamma antagonist is a new therapeutic and prevention option for neuroblastomas.
37970556	13	17	MYCN	Gene	4613
37970556	28	41	neuroblastoma	Disease	MESH:D009447
37970556	66	70	NMYC	Gene	4613
37970556	89	99	PPAR-gamma	Gene	5468
37970556	112	126	Neuroblastomas	Disease	MESH:D009447
37970556	160	172	solid tumors	Disease	MESH:D009369
37970556	391	398	cancers	Disease	MESH:D009369
37970556	438	448	PPAR-gamma	Gene	5468
37970556	475	499	malignant neuroblastomas	Disease	MESH:D009447
37970556	542	546	MYCN	Gene	4613
37970556	557	570	neuroblastoma	Disease	MESH:D009447
37970556	571	577	CHP212	CellLine	CVCL:1125
37970556	604	614	PPAR-gamma	Gene	5468
37970556	626	632	GW9662	Chemical	MESH:C457499
37970556	704	714	PPAR-gamma	Gene	5468
37970556	826	840	tubulin beta 3	Gene	10381
37970556	842	847	TUBB3	Gene	10381
37970556	894	898	MYCN	Gene	4613
37970556	909	922	neuroblastoma	Disease	MESH:D009447
37970556	937	947	PPAR-gamma	Gene	5468
37970556	1007	1011	NMYC	Gene	4613
37970556	1013	1030	B-cell lymphoma 2	Gene	596
37970556	1032	1036	BCL2	Gene	596
37970556	1042	1074	bromodomain-containing protein 4	Gene	23476
37970556	1076	1080	BRD4	Gene	23476
37970556	1102	1106	BRD4	Gene	23476
37970556	1108	1112	NMYC	Gene	4613
37970556	1114	1118	BCL2	Gene	596
37970556	1138	1148	PPAR-gamma	Gene	5468
37970556	1264	1274	PPAR-gamma	Gene	5468
37970556	1304	1310	CHP212	CellLine	CVCL:1125
37970556	1347	1352	tumor	Disease	MESH:D009369
37970556	1436	1441	tumor	Disease	MESH:D009369
37970556	1480	1490	PPAR-gamma	Gene	5468
37970556	1549	1563	neuroblastomas	Disease	MESH:D009447
37970556	Association	MESH:D009447	4613
37970556	Negative_Correlation	5468	596
37970556	Negative_Correlation	MESH:C457499	MESH:D009447
37970556	Positive_Correlation	10381	5468
37970556	Negative_Correlation	4613	5468
37970556	Negative_Correlation	MESH:C457499	5468
37970556	Negative_Correlation	MESH:D009369	5468
37970556	Association	MESH:D009447	5468
37970556	Negative_Correlation	23476	5468

